Neurotechnology
Commercial memory implants
Installing a detailed false memory of an experience the customer never had, complete enough to be indistinguishable from a real one.
In shortCommercial memory implants, from We Can Remember It for You Wholesale (Philip K. Dick, 1966), is at technology readiness level 2 of 9 (technology concept formulated) at its weakest link. Held back by Mechanistic theory of neural computation. Science status: consistent with known physics; key effects unproven at scale. Estimated new funding to unlock: $8.3B–46B (a floor; some parts are priced only to early research).
Rekal Inc. sells Douglas Quail an extra-factual memory of a trip to Mars as a secret agent, packaged with souvenirs to shore up the implant.
Closest todayOptogenetically implanted artificial memories in mice; hippocampal stimulation that improves recall of specific content in epilepsy patients.
Dependency stack
Research TRL 1–3Development TRL 4–6Deployment TRL 7–9
Sort by
- A narrative memory must be expressed in whatever code the hippocampus and cortex use
- Unknown sufficient level of biological detail
plausibleTRL 2- Wiring diagrams constrain and test circuit models
✕3 blockers›
- Human proofreading of AI segmentation dominates cost; 2025 methods imply tens of billions of dollars for one mouse brain
- Imaging throughput and storage; a human brain at EM resolution is of order 100+ exabytes of raw data
- Sectioning or expanding whole large brains without tissue loss or distortion
TRL 3- Ultrastructure must survive preservation before it can be imaged
✕3 blockers›
- Ischemic damage starts within minutes of circulatory arrest, before perfusion can begin
- Aldehyde fixation may destroy molecular state (phosphorylation, receptor conformation) that could carry memory
- No assay proves preserved tissue still contains the information an emulation would need
TRL 4 - Automated segmentation and tracing of exabyte-scale image volumes
✕2 blockers›
- Grid power and interconnection queues
- Advanced-node chip and HBM memory supply
TRL 8
- Installing a chosen memory means writing a specified engram
✕4 blockers›
- Human engrams cannot be labeled; the mouse toolkit depends on transgenic c-fos tagging
- Memory is distributed across an engram complex in many regions, not one addressable site
- Writing content requires knowing the ensemble code for arbitrary experience, which is unknown
- Specificity; stimulation that strengthens one memory also perturbs neighbours
plausibleTRL 3- Writing a memory requires knowing what code represents its contentplausibleTRL 2
- Activity-dependent labeling in humans would need brain-wide gene delivery
✕3 blockers›
- Receptor targeting is species-specific; capsids binding human TfR1 often fail in macaque
- Pre-existing anti-AAV immunity excludes a large fraction of patients and blocks redosing
- Dose needed for brain-wide coverage drives liver toxicity and manufacturing cost
TRL 4- Designed capsid and shuttle proteins are the main route to receptor-specific transcytosis
✕1 blocker›
- Designing catalysis and conformational dynamics
TRL 6
- Engram ensembles must be addressed at single-cell scale in deep structures
✕2 blockers›
- Tissue response degrades signal over years
- Channel count and wireless bandwidth
TRL 6- Channel count is limited by wireless data and power budget
✕3 blockers›
- Tissue heating caps implant power at a few hundred milliwatts, which bounds radio and compute
- Raw broadband neural data exceeds the link, forcing on-implant spike detection and compression
- Battery or wireless-power lifetime versus the decades a permanent interface implies
TRL 5- Implant power density sets what telemetry and on-board compute are affordable
✕2 blockers›
- Cycle life of lithium-metal anodes
- Thermal runaway safety
TRL 6
- Activity-dependent labeling of human engrams would need brain-wide gene deliveryTRL 4
- Engram ensembles in deep structures must be addressed at single-cell scaleTRL 6
- An implanted memory must contain sensory content, not just an association
✕3 blockers›
- Models are subject-specific; decoders do not transfer across brains without recalibration
- Non-invasive signals are slow and spatially coarse; invasive coverage is a few square centimetres
- Encoding (write) models are far behind decoding; we cannot specify the activity for an arbitrary percept
TRL 3- Fast, fine-grained signals needed for anything beyond coarse category decodingTRL 6
- Deep generative and language models supply the latent spaces that brain activity is mapped onto
✕2 blockers›
- Reliability and calibration over long horizons
- Continual learning after deployment
TRL 7- Training and inference computeTRL 8
Who could unlock it
Mechanistic theory of neural computationTRL 2bottleneck
- Philip ShiuResearcher, Eon SystemsBuilt the leaky integrate-and-fire whole fly brain model that predicts sensorimotor circuit responses (Nature 2024)
- Srinivas TuragaResearcher, HHMI Janelia Research CampusCo-led connectome-constrained networks that predict neural activity across the fly visual system (Nature 2024)
- Larry AbbottResearcher, Columbia UniversityTheoretical neuroscientist; co-director of the Zuckerman Institute's Center for Theoretical Neuroscience
- Allen InstituteAcademic labMICrONS functional connectomics and a 230,000-cell biophysical model of mouse visual cortex
Engram-level memory read and writeTRL 3
- Susumu TonegawaResearcher, MIT Picower InstituteHis lab first optogenetically reactivated and implanted false memories in tagged engram cells in mice (2012-2013)
- Sheena JosselynResearcher, SickKids and University of TorontoShowed engram allocation, erasure and artificial memory formation in mice; 2025 Cell paper on stress-inflated engrams
- Steve RamirezResearcher, Boston UniversityEngram manipulation to alleviate maladaptive memory states in mice
- Robert HampsonResearcher, Wake Forest University School of MedicineHippocampal memory-decoding-model stimulation facilitated content-specific recall in epilepsy patients (Front. Comput. Neurosci. 2024)
Systemic delivery of agents across the blood-brain barrierTRL 4
- Benjamin DevermanResearcher, Stanley Center for Psychiatric Research, Broad Institute of MIT and HarvardEngineered BI-hTFR1, an AAV9 capsid reprogrammed to bind human transferrin receptor, giving 40-50x more CNS expression than AAV9 in human TFRC knock-in mice (Science, 2024)
- Denali TherapeuticsCompanyIts TransportVehicle platform produced AVLAYAH (tividenofusp alfa), approved by the FDA in March 2026 as the first biologic specifically designed to cross the blood-brain barrier
- Voyager TherapeuticsCompanyUsed its TRACER platform to find cross-species BBB-penetrant capsids and identified ALPL as the receptor they use; VCAP-102 gave 20-400x more brain gene transfer than AAV9 in primates (2025)
- Sangamo TherapeuticsCompanyReported its STAC-BBB capsid achieving widespread brain transduction after intravenous dosing in non-human primates at clinically relevant doses (2024)
High-density chronic neural interfacesTRL 6
- NeuralinkStartupRaised $650M Series E in 2025; human trials in the US, Canada, UAE and UK
- ParadromicsStartupFDA IDE in November 2025; first participant achieved real-time speech with the fully implanted Connexus BCI (2026)
- Precision NeuroscienceStartupSurface microelectrode arrays in 50+ patients; 2025 Nature Biomedical Engineering paper on minimally invasive delivery
- SynchronStartupRaised $200M Series D in November 2025 (total $345M) for the endovascular Stentrode and a next-generation high-channel interface
Beyond engineering
- Consent when the product is indistinguishable from the customer's own past
- Forensic unreliability of all memory testimony once implants exist